NCT02519231View on ClinicalTrials.gov

Copper IUD Treatment Observation Study

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Menorrhagia
Interventions
DRUG

Naproxen

Naproxen 440mg 1x pid

DRUG

Placebo

Placebo tablet 440mg 1x pid

Trial Locations (5)

60612

John H Stroger Jr Hospital of Cook County, Chicago

98104

Harborview Medical Center, Seattle

98125

UW Neighborhood Clinic Northgate, Seattle

98195

Hall Health Center, Seattle

University of Washington Medical Centers, Seattle

All Listed Sponsors
collaborator

Cook County Hospital

OTHER

collaborator

Teva Pharmaceuticals USA

INDUSTRY

lead

University of Washington

OTHER

NCT02519231 - Copper IUD Treatment Observation Study | Biotech Hunter | Biotech Hunter